Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvage Cellular Immunotherapy for Recurrent Multiple Myeloma
NCT00003153Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jul 1998
- Primary completion
- Feb 2007
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic allogeneic lymphocytes in multiple myeloma (MM), sponsored by Eastern Cooperative Oncology Group. Started Jul 1998; status: completed.
02
Drugs
therapeutic allogeneic lymphocytes
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003153.